Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment

Fritz Boege*, Frank Gieseler, Harald Biersack, Michael Clark

*Korrespondierende/r Autor/-in für diese Arbeit
6 Zitate (Scopus)

Abstract

Fractionation of nuclear extracts from a multi-drug-resistant subclone of the human promyelocytic subline HL-60 by anion-exchange chromatography and chromatofocusing resolves at least two different subtypes of topoisomerase II, which are not identical to the known α- and β-forms of the enzyme because both forms are contained in each subtype. The two subtypes are present in about equal proportions and differ remarkably with respect to the optimum of reaction and sensitivity to m-amsacrine and orthovanadate. Both subtypes are highly insensitive to etoposide inhibition in vitro.

OriginalspracheEnglisch
ZeitschriftJournal of Chromatography A
Jahrgang587
Ausgabenummer1
Seiten (von - bis)3-9
Seitenumfang7
ISSN0021-9673
DOIs
PublikationsstatusVeröffentlicht - 29.11.1991

Fördermittel

This work was supported in part by the Wilhelm-Sander Stiftung, Grant 90 .038 .1, to F .B . and the Deutsche Forschungsgemeinschaft, SFB 172 .. C9 . (F .G .) . The authors are indebted to Professor L . F . Liu for the gift of the rabbit anti-human topoisom-erase II antiserum .

Fingerprint

Untersuchen Sie die Forschungsthemen von „Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren